...
首页> 外文期刊>EBioMedicine >A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
【24h】

A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis

机译:TWEAK / Fn14轴作为血管成形术后再狭窄的治疗靶标的主要作用

获取原文
           

摘要

Background Tumor necrosis factor-like weak inducer of apoptosis ( Tnfsf12 ; TWEAK) and its receptor Fibroblast growth factor-inducible 14 ( Tnfrsf12a ; Fn14) participate in the inflammatory response associated with vascular remodeling. However, the functional effect of TWEAK on vascular smooth muscle cells (VSMCs) is not completely elucidated. Methods Next generation sequencing-based methods were performed to identify genes and pathways regulated by TWEAK in VSMCs. Flow-citometry, wound-healing scratch experiments and transwell migration assays were used to analyze VSMCs proliferation and migration. Mouse wire injury model was done to evaluate the role of TWEAK/Fn14 during neointimal hyperplasia. Findings TWEAK up-regulated 1611 and down-regulated 1091 genes in VSMCs. Using a gene-set enrichment method, we found a functional module involved in cell proliferation defined as the minimal network connecting top TWEAK up-regulated genes. In vitro experiments in wild-type or Tnfrsf12a deficient VSMCs demonstrated that TWEAK increased cell proliferation, VSMCs motility and migration. Mechanistically, TWEAK increased cyclins (cyclinD1), cyclin-dependent kinases (CDK4, CDK6) and decreased cyclin-dependent kinase inhibitors (p15suplNK4B/sup) mRNA and protein expression. Downregulation of p15supINK4B/sup induced by TWEAK was mediated by mitogen-activated protein kinase ERK and Akt activation. Tnfrsf12a or Tnfsf12 genetic depletion and pharmacological intervention with TWEAK blocking antibody reduced neointimal formation, decreasing cell proliferation, cyclin D1 and CDK4/6 expression, and increasing p15supINK4B/sup expression compared with wild type or IgG-treated mice in wire-injured femoral arteries. Finally, immunohistochemistry in human coronary arteries with stenosis or in-stent restenosis revealed high levels of Fn14, TWEAK and PCNA in VSMCs enriched areas of the neointima as compared with healthy coronary arteries. Interpretation Our data define a major role of TWEAK/Fn14 in the control of VSMCs proliferation and migration during neointimal hyperplasia after wire injury in mice, and identify TWEAK/Fn14 as a potential target for treating in-stent restenosis. Fund ISCiii-FEDER, CIBERCV and CIBERDEM.
机译:背景技术肿瘤坏死因子样凋亡的弱诱导物(Tnfsf12; TWEAK)及其受体成纤维细胞生长因子诱导型14(Tnfrsf12a; Fn14)参与与血管重塑相关的炎症反应。但是,尚未完全阐明TWEAK对血管平滑肌细胞(VSMC)的功能作用。方法采用基于下一代测序的方法鉴定TSMC在VSMC中调控的基因和途径。流式细胞仪,伤口愈合刮擦实验和穿孔迁移分析法用于分析VSMC的增殖和迁移。进行小鼠线损伤模型以评估TWEAK / Fn14在新内膜增生中的作用。在VSMC中,TWEAK上调了1611个基因,下调了1091个基因。使用基因集富集方法,我们发现了参与细胞增殖的功能模块,该模块定义为连接顶部TWEAK上调基因的最小网络。在野生型或Tnfrsf12a缺陷型VSMC中进行的体外实验表明,TWEAK增加了细胞增殖,VSMC的运动性和迁移。从机制上讲,TWEAK增加细胞周期蛋白(cyclinD1),细胞周期蛋白依赖性激酶(CDK4,CDK6)并降低细胞周期蛋白依赖性激酶抑制剂(p15 lNK4B )mRNA和蛋白表达。 TWEAK诱导的p15 INK4B 的下调是由有丝分裂原激活的蛋白激酶ERK和Akt激活介导的。与野生型或IgG处理的小鼠相比,Tnfrsf12a或Tnfsf12遗传耗竭和TWEAK阻断抗体的药理干预可减少新内膜形成,减少细胞增殖,cyclin D1和CDK4 / 6表达,并增加p15 INK4B 表达。钢丝受伤的股动脉。最后,与健康冠状动脉相比,患有狭窄或支架内再狭窄的人冠状动脉的免疫组织化学显示,VSMC富集的新内膜区域中Fn1​​4,TWEAK和PCNA的水平较高。解释我们的数据定义了TWEAK / Fn14在小鼠导线损伤后新内膜增生过程中对VSMC增殖和迁移的控制中的主要作用,并确定TWEAK / Fn14是治疗支架内再狭窄的潜在靶标。基金ISCiii-FEDER,CIBERCV和CIBERDEM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号